Novo Nordisk's pricing techniques in the U.S. have drawn sharp criticism from lawmakers like Senator Sanders, that has accused the company of value gouging, stating the stark contrast amongst U.S. prices and people in Europe and copyright.California biotech behemoth Amgen ditched ideas for an experimental weight loss pill in May well but is still h… Read More